Corcept Therapeutics Incorporated (CORT) vs Twist Bioscience Corporation (TWST)

Corcept Therapeutics Incorporated and Twist Bioscience Corporation are both Biotechnology companies. Corcept Therapeutics Incorporated and Twist Bioscience Corporation are of similar size ($7.9B and $7.8B). Twist Bioscience Corporation has negative trailing earnings, so its P/E is not meaningful; Corcept Therapeutics Incorporated trades at 47.8×. Corcept Therapeutics Incorporated grew revenue faster over the last twelve months: 30.0% against 19.2%. Corcept Therapeutics Incorporated has the higher net margin (16.5% vs −31.7%) and the higher return on invested capital (15.0% vs −30.8%). Across the 19 metrics below, Corcept Therapeutics Incorporated leads on 16 and Twist Bioscience Corporation on 3.

Valuation

Metric CORT TWST Biotechnology median
P/E 47.81 n/m 10.60
P/S 8.04 17.25 9.40
P/B 9.29 16.71 2.13
Price to free cash flow 39.79 n/m 25.18
EV/EBITDA 67.93 n/m 0.66
EV/Sales 7.67 16.90 9.02
Earnings yield 2.09% (1.86%) (32.88%)
Free cash flow yield 2.51% (1.28%) (23.13%)

Profitability

Metric CORT TWST Biotechnology median
Gross margin 98.54% 51.97% 68.51%
Operating margin 11.51% (33.58%) 0.00%
Net margin 16.54% (31.66%) 0.00%
Free cash flow margin 20.20% (22.15%) 0.00%
Return on equity 21.74% (29.59%) (51.96%)
Return on assets 17.16% (20.78%) (46.06%)
Return on invested capital 14.97% (30.83%) 0.00%

Growth

Metric CORT TWST Biotechnology median
Revenue growth (TTM) 30.02% 19.19% 6.76%
EPS growth (last fiscal year) (33.33%) 63.89% 29.88%
Revenue growth, 5-year CAGR 16.56% 33.11% 9.75%
Net income growth, 5-year CAGR (1.52%) 0.00% 0.00%

Health

Metric CORT TWST Biotechnology median
Debt to equity 0.00 0.03 0.00
Current ratio 3.00 2.67 4.97
Net debt to EBITDA (8.83) 1.95 1.01

Dividend

Metric CORT TWST Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CORT TWST Biotechnology median
Market cap 7.84b 7.94b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack